|
Speakers – European Life Science CEO Forum
FINANCE AND INVESTMENT ROUNDTABLE –
Chaired by Ken Noonan, Senior Partner, LEK Consulting
with participation from:
Dr. Anthony Hartley, Executive Director, Investment Banking, Lehman Brothers Europe Limited
Antoine Papernik, Managing Partner, Sofinnova Partners
Dr Axel Polack, General Partner, TVM Capital
MEDICAL DEVICES PANEL
Chaired by Klaus Nestler, CEO, BioConnect AG
with participation from:
Markus Bracklo, Partner, Baigo Capital GmbH
Dr Markus Hosang, General Partner, BioMedPartners
Raphaël Wisniewski, Investment Manager, Edmond de Rothschild Investment Partners
Dr Guillaume Connan, Investment Manager, Matignon Technologies
Aris Constantinides, Investment Director, NBGI Ventures
PARTNERING PANEL
Chaired by Dimitri F. Dimitriou, Chief Executive Officer, DyoDelta Biosciences
with participation from:
Jose Maria Romero, Director Worldwide Business Development, GlaxoSmithKline
Dr Margaret Beer, Director, Scientific Liaison, Licensing and External Research, Europe, Merck, Sharp & Dohme
Esteban Pombo Villar, Head of Strategic Alliance Management EU, Novartis Pharma AG
Dr Alex Chanas, Senior Director, Worldwide Licensing and Business Development, Pfizer Inc.
SPECIALITY PHARMA ROUNDTABLE
Chaired by Stephanie Léouzon, Managing Director Healthcare, Credit Suisse
with participation from:
Stefan Aigner, Executive Vice President Corporate Development, Alpharma Inc.
François Thomas, Managing Director, Bioserve Ltd
Jonathan Kwok, European Equity Research - Pharmaceuticals, Exane BNP Paribas
Laurent Feniou, Managing Director Healthcare, Rothschild
VC STRATEGY PANEL
Chaired by Genghis Lloyd-Harris, Partner, Abingworth Management Limited
with participation from:
Dr Raj Parekh, General Partner, Advent Venture Partners
Dr Bruno Montanari, Principal, Atlas Venture
Dr Peter Johann, Partner, NGN Capital
European Life Science Innovation Awards
Chair:
Dimitri F. Dimitriou, Chief Executive Officer, DyoDelta Biosciences
Judges:
Dr Bruno Montanari, Principal, Atlas Ventures
Jose Maria Romero, Director Worldwide Business Development, GlaxoSmithKline
Dr Peter Johann, General Partner, NGN Capital
Dr Alex Chanas, Senior Director, Worldwide Licensing and Business Development, Pfizer Inc.
Sandrine Cailleteau, CBO, Plethora Solutions
Laurent Feniou, Managing Director Healthcare, Rothschild
Dr Deborah Harland, General Partner, SR One
Themes >>> |
| |